Article
Epidermal growth factor receptor mutations as a prognostic factor in Korean patients with advanced lung adenocarcinoma who had not been treated with received epidermal growth factor receptor tyrosine kinase inhibitors.
Chemotherapy - 1 Jan 2011
Kim Seung Tae, Choi Yoon Ji, Park Kyong Hwa, Oh Sang Cheul, Seo Jae Hong, Shin Sang Won, Kim Jun Suk, Kim Yeul Hong
Abstract excerpt
BACKGROUND: Epidermal growth factor receptor (EGFR) mutations as prognostic marker in patients with non-small cell lung cancers remain controversial. In particular, there is only a limited amount of data on the subject in Asian patients with advanced lung adenocarcinomas. PATIENTS AND METHODS: We analyzed 50 patients with advanced lung adenocarcinoma, who received best supportive care with and without cytotoxic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.